Subscribe
marilyn-nieves
marilyn-nieves / iStockphoto.com
7 September 2017Americas

PhRMA and BIO take legal action against Nevada law

Two biotech associations have filed litigation in a district court challenging the provisions of a Nevada law, saying it violates patent rights.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
PhRMA reacts to FDA’s biosimilars guidance
15 August 2014   PhRMA has voiced concerns about the FDA’s draft guidance on biosimilars, which it suggests if enacted, could have an impact on the safety of biosimilar products.
Americas
PhRMA urges USTR to protect US innovation abroad
13 February 2017   The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.
Plant Varieties
Nevada judge overrules objections in patent disclosure suit
20 July 2021   A Nevada federal court judge has overruled objections to a previous ruling on a dispute between investors and cannabidiol company CV Sciences.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Americas
PhRMA reacts to FDA’s biosimilars guidance
15 August 2014   PhRMA has voiced concerns about the FDA’s draft guidance on biosimilars, which it suggests if enacted, could have an impact on the safety of biosimilar products.
Americas
PhRMA urges USTR to protect US innovation abroad
13 February 2017   The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.
Plant Varieties
Nevada judge overrules objections in patent disclosure suit
20 July 2021   A Nevada federal court judge has overruled objections to a previous ruling on a dispute between investors and cannabidiol company CV Sciences.

More on this story

Americas
PhRMA reacts to FDA’s biosimilars guidance
15 August 2014   PhRMA has voiced concerns about the FDA’s draft guidance on biosimilars, which it suggests if enacted, could have an impact on the safety of biosimilar products.
Americas
PhRMA urges USTR to protect US innovation abroad
13 February 2017   The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.
Plant Varieties
Nevada judge overrules objections in patent disclosure suit
20 July 2021   A Nevada federal court judge has overruled objections to a previous ruling on a dispute between investors and cannabidiol company CV Sciences.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent